We next tested whether the specific ablation of MAVS in only hepatocytes would be sufficient to ameliorate MASLD in mice fed an MCD diet for 4 weeks or mice fed a WD for 9 weeks (Supplemental Table S1, http://links.lww.com/HEP/I457). This evidence concerns the gene MAVS and metabolic dysfunction-associated steatotic liver disease.